Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment

2019 ◽  
Vol 567 ◽  
pp. 118415 ◽  
Author(s):  
Prachi Shekhawat ◽  
Varsha Pokharkar
Sign in / Sign up

Export Citation Format

Share Document